The lung cancer death rate curve suggests that whatever ... index for the amount of increase and because of their heterogeneous nature, it is most difficult to establish their relationship to ...

The role of immune-tumor cell interactions in lung adenocarcinoma (LUAD ... The clinical implications of molecular heterogeneity in HER2-positive breast cancer remain to be explored.

The immune microenvironment and heterogeneity of lung cancer tumours are the major barriers to immunotherapy, explains Lu. “We are looking to improve the efficacy of T cell therapy while ...

Tuomas Tammela, MD, PhD Cancer biologist Tuomas Tammela investigates cellular heterogeneity in lung and pancreatic cancers. Craig B. Thompson, MD Craig Thompson studies molecular signaling pathways ...

Sabari, MD, which focused on the approval of amivantamab plus lazertinib in the first line, he looks ahead to potential uses ...

By inferring proliferation rates from single-cell genomics, SPRINTER enhances understanding of tumor evolution and identifies ...